|
|
Volumn 41, Issue 5, 2002, Pages 333-340
|
|
One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
CROMOGLYCATE DISODIUM;
FLUNISOLIDE;
TETRACOSACTIDE;
VANCERIL DS;
ANTIASTHMATIC AGENT;
BECLOMETASONE;
DRUG DERIVATIVE;
FLUOCINOLONE ACETONIDE;
ARTICLE;
ASTHMA;
CANDIDA ALBICANS;
CHILD;
CHILD GROWTH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
ELECTROCARDIOGRAM;
FEMALE;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS SYSTEM;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
MALE;
PHYSICAL EXAMINATION;
RANDOMIZED CONTROLLED TRIAL;
SUSPENSION;
THROAT CULTURE;
CHEMICALLY INDUCED DISORDER;
CHILD DEVELOPMENT;
COMPARATIVE STUDY;
GROWTH DISORDER;
GROWTH, DEVELOPMENT AND AGING;
HOSPITALIZATION;
HYPOPHYSIS;
HYPOTHALAMUS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PRESCHOOL CHILD;
TIME;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
CHILD;
CHILD DEVELOPMENT;
CHILD, PRESCHOOL;
COMPARATIVE STUDY;
CROMOLYN SODIUM;
FEMALE;
FLUOCINOLONE ACETONIDE;
GROWTH DISORDERS;
HUMAN;
HYPOTHALAMUS;
MALE;
PITUITARY GLAND;
SEVERITY OF ILLNESS INDEX;
SUPPORT, NON-U.S. GOV'T;
TIME FACTORS;
HUMANS;
|
|
EID: 0036599577
PISSN: 00099228
EISSN: None
Source Type: Journal
DOI: 10.1177/000992280204100506 Document Type: Article |
|
Times cited : (25)
|
|
References (17)
|
